Logo
x

Search

Subscribe Now

Agreement

Viatris Join Forces with Lexicon Pharmaceuticals to Commercialize Sotagliflozin Across all Markets Outside of the US and EU

Viatris Join Forces with Lexicon Pharmaceuticals to Commercialize Sotagliflozin Across all Markets Outside of the US and EU

  • October 17, 2024
Boehringer Ingelheim Join Forces with Circle Pharma to Develop a Novel Precision Cancer Treatment

Boehringer Ingelheim Join Forces with Circle Pharma to Develop a Novel Precision Cancer Treatment

  • October 10, 2024
Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program

Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program

  • October 9, 2024
Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

  • October 4, 2024
Prime Medicine and BMS Join Forces to Develop and Commercialize Various Prime Edited Ex Vivo T-Cell Therapies

Prime Medicine and BMS Join Forces to Develop and Commercialize Various Prime Edited Ex Vivo T-Cell Therapies

  • October 1, 2024
Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots

Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots

  • September 30, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.